Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease. B-cell receptor (BCR) pathway is essential for malignant B-cell growth, survival, and proliferation. Various immune cells, including T-cells and macrophages in the tumor microenvironment (TME) contribute to tumor cell survival and pat...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
MDPI AG
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/a418c832eb2f477cb6afc86424d80a53 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|